Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.38)
# 3,248
Out of 4,829 analysts
50
Total ratings
48.39%
Success rate
-6.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Overweight | $136 → $147 | $133.24 | +10.33% | 5 | Apr 17, 2025 | |
| PODD Insulet | Maintains: Overweight | $305 → $322 | $310.67 | +3.65% | 4 | Feb 21, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $12.95 | +54.50% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $22.98 | +256.83% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $125.11 | +98.23% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $167.22 | +64.45% | 4 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $536.51 | -36.81% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $3.01 | -50.17% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $3.37 | +701.19% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $95.21 | +16.58% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $84.67 | +69.78% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $89.96 | -37.75% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $95.83 | -22.78% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $73.68 | +4.06% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $17.38 | +417.84% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $55.82 | - | 1 | Dec 12, 2019 |
Abbott Laboratories
Apr 17, 2025
Maintains: Overweight
Price Target: $136 → $147
Current: $133.24
Upside: +10.33%
Insulet
Feb 21, 2025
Maintains: Overweight
Price Target: $305 → $322
Current: $310.67
Upside: +3.65%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $12.95
Upside: +54.50%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $22.98
Upside: +256.83%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $125.11
Upside: +98.23%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $167.22
Upside: +64.45%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $536.51
Upside: -36.81%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $3.01
Upside: -50.17%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $3.37
Upside: +701.19%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $95.21
Upside: +16.58%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $84.67
Upside: +69.78%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $89.96
Upside: -37.75%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $95.83
Upside: -22.78%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $73.68
Upside: +4.06%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $17.38
Upside: +417.84%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $55.82
Upside: -